Health and Healthcare
5867 Articles
Boston Scientific (BSX) has been the "gang who couldn’t shot straight" of the medical device business for some time. It…
Chelsea Therapeutics International, Ltd. (NASDAQ: CHTP) falling today after first quarter earnings showed wider losses than first quarter 2007. Net…
AMAG Pharmaceuticals (NASDAQ: AMAG) has been added to the Nasdaq Biotechnology Index (NASDAQ: NBI) beginning May 19, 2008. AMAG shares…
Cell Genesys, Inc. (NASDAQ: CEGE) plans to offer 7.1 million shares of common stock and warrants at an equivalent of…
Who thought generics could ever look so bad? This morning, Barr Pharmaceuticals (NYSE: BRL) has posted very poor numbers. The…
REGENERX BIOPHARMACEUTICALS, INC. (AMEX: RGN) filed for a secondary offering late yesterday to sell some $60 million in a secondary…
Here are some of the top stories today that affecting key drug and biotech stocks: GlaxoSmithKline (NYSE: GSK) reorganized its…
WuXi PharmaTech (Cayman) Inc. (NYSE: WX) announced today that it has decided to postpone its follow-on offering of American Depository…
Big Pharma continues to throw ballast out of the balloon in the hopes of staying aloft. The latest victim of…
Cougar Biotechnology, Inc. (NASDAQ: CGRB) is up over 5% in afternoon trading on the announcement that they will present a…
There are lots of names moving in biotech and related fields today, and below are some of the top movers:…
Generex Biotechnology Company (NASDAQ: GNBT), a drugdelivery system and technology developer, has filed an offering by sellingstockholders of up to…
Sun Healthcare Group (NASDAQ: SUNH) has filed for a mixed shelfoffering of $200 million this morning. They may periodically offer…
Today almost feels like the "March of Biotech-inguins" because most of the movers were small companies you might otherwise miss. …
Genentech, Inc. (NYSE:DNA) and Biogen Idec, Inc. (Nasdaq:BIIB) came out this morning with some disappointing news. The biotech giants have…
Our top personal finance-related articles today. Your wallet will thank you later.